Operator Greetings and welcome to the 3D Systems fourth quarter and fiscal year 2024 earnings conference call and webcast. At ...

Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the first patient has been dosed in its Phase IIa trial of ALY-101 in patients suffering from Alopecia ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 annual results as of 31 December 2024. Financial ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced the publication ...

A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...

In a medical first, a research team in China has successfully stitched a CRISPR gene-edited pig liver into a brain-dead ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8720 ...

The American Association for the Advancement of Science, one of the world’s largest general scientific societies and publisher of the Science family of journals, announces the 2024 class of AAAS ...

Everything you need to know about a molecule discovered in bottlenose dolphins the US Navy trains to protect ships and harbors.